| Source: |
| Type: protein |
| Trx is a small protein that acts as a reducing agent, donating electrons to reduce oxidized proteins and other molecules. Trx is overexpressed in various types of cancer, including breast, lung, colon, and prostate cancer. - Cytosolic thioredoxin (TRX-1) and mitochondrial thioredoxin (TRX-2). - Thioredoxin is a pivotal redox regulator that protects cells from oxidative stress and supports survival and proliferation. - There is interest in combining thioredoxin inhibitors with conventional chemotherapy or radiotherapy to sensitize tumors to oxidative stress and improve treatment efficacy. |
| 9209- | BITC, | ITCs, | SFN, | PEITC, | Effect of Isothiocyanates on Nuclear Accumulation of NF-κB, Nrf2, and Thioredoxin in Caco-2 Cells |
| - | in-vitro, | Colon, | Caco-2 |
| 4513- | GLA, | Antineoplastic Effects of Gamma Linolenic Acid on Hepatocellular Carcinoma Cell Lines |
| - | in-vitro, | Liver, | HUH7 |
| 9191- | ITCs, | AITC, | BITC, | PEITC, | SFN | Molecular Targets of Isothiocyanates in Cancer: Recent Advances |
| - | Review, | Var, | NA |
| 8757- | MeSA, | Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system |
| - | in-vitro, | BC, | T47D |
| 3302- | SIL, | Protective effects of silymarin in glioblastoma cancer cells through redox system regulation |
| - | in-vitro, | GBM, | U87MG |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:824 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid